About Agnitio Pharma
Agnitio Pharma offers products and services including Active Pharmaceutical Ingredients and Custom Synthesis.
- SectorsIndustrial Goods & ManufacturingHealthcare
- Phone•••• ••••
- Legal Name Agnitio Solutions Pvt. Ltd.
- Date of Incorporation 03 Dec, 2015
- Jurisdiction Noida, Uttar Pradesh, India
- Annual Revenue₹2.52 Cr
FY 2024 · +4% YoY
- Net Profit₹0.23 Cr
FY 2024 · 9% margin
- EBITDA₹0.35 Cr
FY 2024 · 14% margin
Associated legal entities of Agnitio Pharma
Agnitio Pharma operates through Agnitio Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Agnitio Solutions Private Limited CIN U72300UP2015PTC074815 | Active | 03 Dec 2015 | Noida, Uttar Pradesh | ₹2.5 Cr | – | 2 | View details |
Products & Services of Agnitio Pharma
Agnitio Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Custom Synthesis.
Active Pharmaceutical Ingredients are developed and supplied for therapeutic uses by Agnitio Pharma.
Custom synthesis of chemical compounds is conducted for pharmaceutical applications by Agnitio Pharma.
Board of directors of Agnitio Solutions Private Limited (Agnitio Pharma)
Agnitio Solutions Private Limited is the primary company behind Agnitio Pharma. The board of Agnitio Solutions Private Limited currently have 2 directors; the longest-serving is Kusum Lata, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kusum Lata DIN 07303012 | Director | 03 Dec 2015 | 10 yrs 10 mo | Agnitio Solutions Private Limited |
| Naresh Kumar Bansal DIN 07302312 | Director | 03 Dec 2015 | 10 yrs 10 mo | Agnitio Solutions Private Limited |
Financials of Agnitio Pharma
Figures of Agnitio Solutions Private Limited, the primary company behind Agnitio Pharma, for FY 2024. Revenue was ₹2.52 Cr (+4% year on year). Net profit was ₹0.23 Cr (9% margin). EBITDA was ₹0.35 Cr (14% margin). Revenue has grown at a compounded annual rate of +17% over three years and +11% over five years.
- ₹2.52 CrRevenue · FY 2024 · +4% YoY
- ₹0.23 CrNet profit · 9% margin
- ₹0.35 CrEBITDA · 14% margin
- ₹0.01 CrPaid-up capital
- +17%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Agnitio Solutions Private Limited are on its company page.
Detailed financial statements for Agnitio Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Agnitio Pharma
10 companies that operate in the same segment as Agnitio Pharma (Materials Research & Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Advanced materials and precision components are manufactured for diverse sectors. | 1931 | Cleveland, Ohio, United States | – | USD 1.79 B | 3,040 | |
Provider of surface treatment services for metal forming, and other materials | 1982 | Frankfurt Am Main, Hesse, Germany | – | USD 37.39 M | 129 | |
Burners and combustion systems are supplied for industrial applications. | 1934 | Pittsburgh, Pennsylvania, United States | – | USD 8.5 M | 47 | |
Linear motion systems are researched, manufactured, and distributed globally. | 2000 | Shaoxing, Zhejiang, China | – | USD 574.2 M | – | |
Cryogenic systems and measurement instruments for low-temperature research are manufactured. | 1968 | United States | – | – | – | |
Graphite exploration and development services are provided. | 2006 | Vancouver, British Columbia, Canada | – | – | – | |
Mineral exploration and development innovations are fostered through collaborative communities. | 2015 | Berlin, Berlin, Germany | – | – | – | |
Offers comprehensive solutions in graphite and carbon products for industrial applications. | – | Mumbai, Maharashtra, India | – | USD 1.29 M | 23 | |
Nanoscale materials research services are provided by the organization. | 1880 | Dubendorf, Zurich, Switzerland | – | – | – | |
Provider of research & development services for magnetic & fabricated materials | 1956 | Tokyo, Tokyo, Japan | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Agnitio Pharma
The primary company behind Agnitio Pharma, Agnitio Solutions Private Limited, reported revenue of ₹2.52 Cr for FY 2024, up 4% year on year.
Agnitio Pharma is identified as a research-oriented organization that was established in 2018 in Noida, Uttar Pradesh, India. Expertise in synthetic organic chemistry is demonstrated by its team, which includes professionals in medicinal chemistry, custom synthesis, and generic product development for APIs and intermediates. Clinical research, toxicology, analytical services, process development, and intellectual property are covered in its operations. High-quality pharmaceutical standards, impurities, and metabolites are developed by Agnitio Pharma to support innovation in the field.
Agnitio Pharma offers Active Pharmaceutical Ingredients and Custom Synthesis.
Agnitio Pharma operates through Agnitio Solutions Private Limited.
The legal entities of Agnitio Pharma currently have 2 directors, including Kusum Lata, Naresh Kumar Bansal.